|
May 2013 FAQs
What available alternatives are there to papaverine for the prevention and management of vasospasm during cardiac procedures?
What are the alternatives to alteplase for catheter clearance?
How do methylene blue and isosulfan blue compare for use in sentinel lymph node biopsy?
April 2013 FAQs
What are the differences between the recent American Society of Clinical Oncology (ASCO) guideline on antibiotic use for neutropenia and those from the Infectious Diseases Society of America (IDSA)?
What data are available to guide appropriate off-label use of the peripheral mu-opioid receptor antagonists, methylnaltrexone and alvimopan?
What are the risk factors associated with supratherapeutic dosing of acetaminophen in hospitalized patients?
March 2013 FAQs
What are aminophylline alternatives for the reversal of adenosine agonists used in pharmacologic stress testing?
What are the new recommendations for frequency of platelet monitoring in patients with heparin-induced thrombocytopenia?
What are the new guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients?
February 2013 FAQs
What are the updated guideline recommendations for management of pain, agitation, and delirium in critically ill adult patients?
Drug-induced QT prolongation (Part 2): a focus on select medications
What are the new clinical guidelines for the management of gastroparesis?
January 2013 FAQs
Does parenteral iron administration increase the risk of infection?
Drug-induced QT prolongation (Part 1): presentation, risks, and management
Should tamoxifen therapy be extended up to 10 years in women with early breast cancer?
Archives
FAQs 2012
FAQs 2011
FAQs 2010
FAQs 2009
FAQs 2008
FAQs 2007
FAQs
2006
FAQs 2003
| 
